Study S002698

Evaluating the Effect of a Food for Special Medical Purposes Containing Essential Amino Acids (EAA), Carnitine, Arginine, and Sucrosomial Minerals on the Preservation of Appendicular Skeletal Muscle Mass (ASMM) During a Weight Loss Program With GLP-1 Receptor Agonists

ClinicalTrials.gov record

Registration

Registration: NCT07393360
Acronym: MYO-PRESERVE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 144
Start: 2025-12-11
Primary completion: 2026-12
Lead sponsor: Pharmanutra S.p.a.
Conditions: Obesity & Overweight
Interventions: DIETARY_SUPPLEMENT:Myosave®; OTHER:Placebo
Results posted: FALSE

Registered primary outcomes

Change in Appendicular Skeletal Muscle Mass (ASMM) [Baseline, Week 8, Week 16, Week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.